Our data suggest that a reduction in adiponectin expression, as seen in diabetes and obesity, is sufficient to promote a pro-atherogenic environment in the aorta and circulation. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.